Abstract
Background: Regorafenib is a multikinase inhibitor, indicated for the treatment of metastatic colorectal cancer and locally advanced, unresectable or metastatic gastrointestinal stromal tumor.
Objective: A simple and fast, validated bioanalytical method is required for pre-clinical or clinical safety and efficacy investigations and possible pharmacokinetic interaction of regorafenib.
Method: Regorafenib and sorafenib were eluted on Acquity UPLC®BEH C18 column. Elution was carried out by pumping mobile phase [methanol (0.1% formic acid): water (85:15%)] at 200µl/min flow rate. Mass detector was operated in multiple-reaction monitoring mode. Deprotonated ions [M-H]- of regorafenib and sorafenib were fragmented and monitored.
Results: Daughter fragments of regorafenib (m/z 481.1 > 194, m/z 481.1 > 260) and sorafenib (m/z 463 > 193.99, m/z 463 > 268.1) were determined in negative electrospray ionization mode. Linear calibration curve of range 50-2500 ng/ml was prepared in plasma. Method was selective, since there was no interfering peak at regorafenib retention time. Coefficients of variation for inter-day precision at three quality control concentrations were 17.6% at lower limit of quantitation, 6.3% at middle limit, and 2.9% at the highest limit of quantitation. Accuracy of the method ranged between 96% to 105.3%. Recovery of drug from blank plasma at quality control concentrations varied between 82.53 to 105.66%.
Conclusion: The developed method was successfully validated by adopting US FDA guidance for bioanalytical methods. The method is simple, quick and can be adopted for regorafenib estimation in other biological fluids with necessary modifications.
Keywords: Regorafenib, sorafenib, pharmacokinetics, bioanalysis, UPLC-MS/MS, elution.
Current Analytical Chemistry
Title:Rapid UPLC Tandem Triple Quadrupole Mass Spectrometry Method for Determination of Regorafenib in Plasma
Volume: 14 Issue: 6
Author(s): Mohd Aftab Alam*, Fahad Ibrahim Al-Jenoobi, Ahmed Abdelrahman Abdelgalil and Abdullah Mohammed Al-Mohizea
Affiliation:
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh,Saudi Arabia
Keywords: Regorafenib, sorafenib, pharmacokinetics, bioanalysis, UPLC-MS/MS, elution.
Abstract: Background: Regorafenib is a multikinase inhibitor, indicated for the treatment of metastatic colorectal cancer and locally advanced, unresectable or metastatic gastrointestinal stromal tumor.
Objective: A simple and fast, validated bioanalytical method is required for pre-clinical or clinical safety and efficacy investigations and possible pharmacokinetic interaction of regorafenib.
Method: Regorafenib and sorafenib were eluted on Acquity UPLC®BEH C18 column. Elution was carried out by pumping mobile phase [methanol (0.1% formic acid): water (85:15%)] at 200µl/min flow rate. Mass detector was operated in multiple-reaction monitoring mode. Deprotonated ions [M-H]- of regorafenib and sorafenib were fragmented and monitored.
Results: Daughter fragments of regorafenib (m/z 481.1 > 194, m/z 481.1 > 260) and sorafenib (m/z 463 > 193.99, m/z 463 > 268.1) were determined in negative electrospray ionization mode. Linear calibration curve of range 50-2500 ng/ml was prepared in plasma. Method was selective, since there was no interfering peak at regorafenib retention time. Coefficients of variation for inter-day precision at three quality control concentrations were 17.6% at lower limit of quantitation, 6.3% at middle limit, and 2.9% at the highest limit of quantitation. Accuracy of the method ranged between 96% to 105.3%. Recovery of drug from blank plasma at quality control concentrations varied between 82.53 to 105.66%.
Conclusion: The developed method was successfully validated by adopting US FDA guidance for bioanalytical methods. The method is simple, quick and can be adopted for regorafenib estimation in other biological fluids with necessary modifications.
Export Options
About this article
Cite this article as:
Alam Aftab Mohd*, Al-Jenoobi Ibrahim Fahad, Abdelgalil Abdelrahman Ahmed and Al-Mohizea Mohammed Abdullah, Rapid UPLC Tandem Triple Quadrupole Mass Spectrometry Method for Determination of Regorafenib in Plasma, Current Analytical Chemistry 2018; 14 (6) . https://dx.doi.org/10.2174/1573411014666171204155553
DOI https://dx.doi.org/10.2174/1573411014666171204155553 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
Bioanalytical and Biosensor Technologies for Target Molecules
Bioanalytical and biosensor technologies constitute the core of detecting and sensing diverse molecules within living organisms, encompassing proteins, DNA, small molecular metabolites, and beyond. These molecules assume pivotal roles in biological processes, rendering their analysis and sensing indispensable for comprehending biological phenomena and unraveling disease mechanisms. In the current landscape ...read more
Biogeochemistry: global environmental research and management
his issue focuses on the bio-pathways of trace elements (Ni, Co, Cr, Mn, Cd, Pb, Zn and REE) in soil, plant and atmospheric systems. Specific interest in the application of phytotechnologies that utilise hyperaccumulator plants (agro/phytomining). On the basis of understanding the migration and transformation of trace elements in ecosystem, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Dynamics Simulation and Docking Studies of Selenocyanate Derivatives as Anti-Leishmanial Agents
Combinatorial Chemistry & High Throughput Screening The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment
Current Cancer Drug Targets The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
Current Drug Delivery Topoisomerases and Tubulin Inhibitors: A Promising Combination for Cancer Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Tumor Biomarkers: Clinical Utility, Promises and Problems
Applied Clinical Research, Clinical Trials and Regulatory Affairs Modulation of Angiogenesis for Cancer Prevention: Strategies Based On Antioxidants and Copper Deficiency
Current Pharmaceutical Design Onco-Surgical Management of Colo-Rectal Liver Metastases in Older Patients: A New Frontier in the 3<sup>rd</sup> Millennium
Anti-Cancer Agents in Medicinal Chemistry A Functional Scaffold in Marine Alkaloid: An Anticancer Moiety for Human
Current Medicinal Chemistry Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer
Current Chemical Biology Complex Network and Gene Ontology in Pharmacology Approaches:Mapping Natural Compounds on Potential Drug Target Colon Cancer Network
Current Bioinformatics Immunotoxicity, Flow Cytometry, and Chemoinformatics: Review, Bibliometric Analysis, and New QSAR Model of Drug Effects Over Macrophages
Current Topics in Medicinal Chemistry Telomerase as a Cancer Target. Development of New Molecules
Current Topics in Medicinal Chemistry CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
Current Medicinal Chemistry Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Treatment of Estrogen Receptor-Positive Breast Cancer
Current Medicinal Chemistry Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
Current Cancer Drug Targets Cucurbitacins as Inducers of Cell Death and a Rich Source of Potential Anticancer Compounds
Current Pharmaceutical Design Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies
Current Molecular Medicine Potential of Selected Antioxidants for Influenza Chemotherapy
Anti-Infective Agents in Medicinal Chemistry